All In Biotech

Drug Trial Radar · NCT06940154

Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)

A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Participants With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 159 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

159

Actual

Start

Aug 12, 2025

Primary completion

Jul 30, 2026

Study completion Aug 26, 2026

Sponsor

Lead sponsor
Connect Biopharm LLCIndustry
Sponsor type
Industry
First posted
Apr 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2, multicenter study in adult participants with an acute COPD exacerbation and type 2 inflammation

Conditions

  • COPD Acute Exacerbation

Interventions

  • Rademikibart in prefilled syringeCombination product

    Participants receive 600 mg (4mL) of rademikibart administered subcutaneously.

  • Matching placebo in prefilled syringeDrug

    Participants receive 4mL of placebo matched to rademikibart administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment failure rateTime frame: 28 days

Locations

52 sites in 6 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Lung Health Center

    Birmingham, Alabama

  • Leland Stanford Junior University, Stanford Hospital

    Palo Alto, California

  • Amicis Research Center

    Valencia, California

  • National Jewish Health

    Denver, Colorado

  • Columbus Clinical Services, LLC

    Miami, Florida

  • Pharmax Research of South Florida, Inc.

    Miami, Florida

  • Health Synergy Clinical Research, LLC

    West Palm Beach, Florida

  • Primeway Clinical Research Group

    Fayetteville, Georgia

  • Pivotal Research Solutions

    Stonecrest, Georgia

  • University of Iowa

    Iowa City, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Ochsner Medical Complex - The Grove

    Baton Rouge, Louisiana

  • Stony Brook University Hospital

    Stony Brook, New York

  • Duke Asthma, Allergy, and Airway Center

    Durham, North Carolina

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Clinical Research of Rock Hill

    Rock Hill, South Carolina

  • Inquest Clinical Research

    Baytown, Texas

  • Premier Pulmonary Critical Care and Sleep Medicine

    Denison, Texas

  • DCT- McAllen Primary Care Research, LLC dba Discovery Clinical Trials

    McAllen, Texas

  • Vermont Lung Center

    Colchester, Vermont

  • Carilion Medical Center / Carilion Roanoke Memorial Hospital

    Roanoke, Virginia

  • Centro de Diagnostivo y Rehabilitación S.A. - CEDIR

    Santa Fe, Argentina

  • Hospital Italiano de Buenos Aires

    CABA, Buenos Aires, Argentina

  • CEMER - Centro Medico de Enfermedades Respiratorias

    Florida, Buenos Aires, Argentina

  • Instituto Ave Pulmo-Fundacion Enfisema

    Mar del Plata, Buenos Aires, Argentina

  • Centro de Investigaciones Médicas Mar del Plata

    Mar del Plata, Buenos Aires, Argentina

  • Hospital Universitario Austral

    Pilar, Buenos Aires, Argentina

  • Centro Medico Ipam S.A

    Rosario, Santa Fe Province, Argentina

  • Investigaciones en Patologias Respiratorias SRL

    San Miguel de Tucumán, Tucumán Province, Argentina

  • The Canberra Hospital

    Garran, Australian Capital Territory, Australia

  • Campbelltown Hospital

    Campbelltown, New South Wales, Australia

  • St. Vincent's Hospital Sydney

    Darlinghurst, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Sunshine Coast University Hospital

    Birtinya, Queensland, Australia

  • Bendigo Health

    Bendigo, Victoria, Australia

  • Institute for Respiratory Health

    Nedlands, Western Australia, Australia

  • JSC "National Center for Lung Health"

    Tbilisi, Georgia

  • LLC "Israel-Georgian Medical Research Clinic Healthycore"

    Tbilisi, Georgia

  • Acad. Chapidze Emergency Cardiology Center LLC

    Tbilisi, Georgia

  • Acad. G. Chapidze Emergency Cardiology Center

    Tbilisi, Georgia

Showing 40 of 52 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.